Las Vegas, NV (PRWEB) January 28, 2004
Las Vegas, Nevada– Clinical development company, NanoSignal Corporation (Stock Sign = NNOS) continues to expand operations, providing financiers an unique high return stock investment revenue opportunity. See http://www.nnos.net
. NEW MRI TECHNOLOHY – NanoSignal’s new Magnetic Resonance Imaging (MRI) improvement innovation product with digital imaging functions, SLICES, allows physicians and radiologists to perform advanced MR imaging testing that exceeds the abilities of the basic MRI pc. The product is being Beta checked at Desert Radiology of Las Vegas. For news launches and even more details on screening browse through http://www.nnos.net/mri.htm .
. MEDICAL EXPENSE COST SAVINGS – SLICES offers a clinical cost containment option by permitting much shorter MR scan times (up to 50 %) and decreasing operating expense through minimized film consumption (from 30 % to 80 %) as well as extending the life of older MRI units.
. For total details on the clinical cost containment option and perks provided by this new innovation check out http://www.nnos.net/medical-costs.htm .
. With testing finished a complete advertising and marketing and sales campaign directed to MRI centers, healthcare facilities and radiology practice teams is readied to start.
. EARLY STROKE DETECTION – See the brand-new page http://www.nnos.net/stroke-detection.htm .
. BRAND-NEW APPLICATIONS – CNN and the Exchange Journal recently reported on brand-new MRI applications including non-invasive autopsies and amnesia prediction. SLICES capacity to provide enhanced imaging and enhanced information control and archiving opens these new markets.
. In addition, the Business is likewise developing blood flow monitor capacities (http://www.nnos.net/blood-flow.htm) for use in cancer cells medical diagnosis and cardio treatments. These advances would provide noninvasive, very early analysis of vascular stricture and illness detection making use of current MRI devices.
. NANOTECHNOLOGY and NANOMEDICINE EXPANSION– The Company’s stock symbol and name modification reflects their growth into the expanding new sciences of nanotechnology and nanomedicine. See http://www.nnos.net/nanotechnology.htm .
. The next generation of SLICES is being developed to assist research researchers and physicians extensively inventory cells, cell parts and molecules within cell parts.
. NanoSignal’s business website (http://www.nanosignalcorp.com) includes in-depth info on the benefits and capacities of SLICES.
. Note: Certain statements in this news release could contain “forward looking statements” within the meaning of Personal Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor created by those regulations. This launch is for information functions only. NanoSignal Company has neither approved nor rejected this release. This launch is not an offer or solicitation to purchase protections. This information ought to not be considered to be any kind of financial investment opinion or insight. These statements are not guarantees of future outcomes or efficiency.
.
# # #
.
.
.
.
.